abciximab Vials, injection 10 mg/5ml

It is a biotech company founded in the 2000s with a focus on orphan drugs and rare diseases. It has been building various new drug pipelines such as immuno-oncology and intractable disease treatment by steadily focusing on the development of antibody therapeutics. The vision of the company as a global bio company that adds abundance and convenience to life and creates a better future by providing new treatment methods to cancer and incurable disease patients around the world with antibody development technology.